PDS Biotechnology CFO Lars Boesgaard to resign, interim replacements named

PDS Biotechnology Corporation disclosed in an SEC filing that Lars Boesgaard notified the company on August 13, 2026 that he would step down as Chief Financial Officer and as the company's principal financial and accounting officer, with the resignation taking effect September 12, 2026, to pursue other professional opportunities.¹ The filing noted that Boesgaard confirmed his departure was not tied to any disagreement over the company's operations, policies or practices.¹

To fill the roles, the board on August 19, 2026 named Janetta Trochimiuk, who serves as the company's Controller, to take over as interim principal accounting officer, while Frank Bedu-Addo, Ph.D., the company's President and CEO, will serve as interim principal financial officer, both appointments effective September 12, 2026.¹

According to the filing, Trochimiuk joined the company as Controller in December 2019 and brings more than 25 years of experience in controller and CFO roles at various corporations.¹ Her earlier career included stints as Controller at Delcath Systems, Inc. in New York from April 2017 to July 2019, Controller and CFO of Westwood Consulting Group, LLC from October 2012 to January 2017, regional CFO at Ceragon Networks, Inc. from January 2009 to October 2012, and Controller North America at Olam Americas, Inc. from November 2005 to September 2007.¹ She holds a Bachelor of Business Administration from Bernard M. Baruch College and is a licensed CPA.¹

The filing stated that there are no family relationships between Trochimiuk and other company directors or executives, and no arrangements or understandings tied to her appointment.¹ Per the filing, Trochimiuk will keep her base salary of $279,519.57 per year and remains eligible for equity awards under the company's equity incentive plan, though she did not receive new equity in connection with the promotion.¹